IQVIA said it held its 2025 Annual Meeting of Stockholders on April 24, 2025, and that 176,315,036 shares of common stock were outstanding and entitled to vote as of the record date of February 24, 2025.

1. 01

   IQVIA said it held its 2025 Annual Meeting of Stockholders on April 24, 2025, and that 176,315,036 shares of common stock were outstanding and entitled to vote as of the record date of February 24, 2025.

2. 02

   The company said stockholders approved an amendment to its charter to provide for officer exculpation to the fullest extent permitted by Delaware law and to remove obsolete provisions relating to its previous classified board structure. It said the amended charter became effective upon filing with the Delaware Secretary of State on April 24, 2025.

3. 03

   IQVIA said 9 director nominees were elected by majority vote to one-year terms, with 1 votes for each nominee. It said the advisory vote on 2024 executive compensation received 125,637,769 votes for and 26,212,786 against, and the ratification of PricewaterhouseCoopers LLP received 145,558,841 votes for and 14,744,090 against.

4. 04

   The company said the officer exculpation charter amendment was approved with 138,590,858 votes for and 13,662,237 against. It said the advisory, non-binding stockholder proposal on special stockholder meetings received 66,155,724 votes for and 86,013,439 against.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.